therapeutics News and Research

RSS

University of Utah Study Identifies Arc Protein as Alzheimer's Driver

Alzheimer's disease is driven by a buildup of a toxic protein called Tau that kills neurons. As toxic Tau spreads to new regions of the brain, symptoms become worse and ultimately fatal.

30 Jun 2026

Researchers Develop Non-Toxic Way to Generate the Symptoms of Parkinson's Disease

Scientists usually use animal models when studying Parkinson's disease because these models mimic the disease well.

30 Jun 2026

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 26 Jun 2026

Targeting Fibroblast Communication Could Halt Primary Sjögren Disease Damage

In autoimmune disorders, immune cells targeting 'self' proteins are mistakenly activated, resulting in their abnormal expansion and responsiveness. It has been known to reduce the quality of life of patients over a prolonged period.

25 Jun 2026

Automated Cell-Free Systems Boost Protein Production Performance Five-Fold

A research team led by Professor Joongoo Lee in the Department of Chemical Engineering at POSTECH (Pohang University of Science and Technology) has developed an automated, modular method for assembling reconstituted cell-free systems, which are test-tube systems that can produce proteins outside living cells.

25 Jun 2026

Immune Pathway Breakthrough Reveals Critical Sex Differences in Female Glioblastoma

Researchers have identified a critical biological difference in how glioblastoma develops in male and female laboratory models, pinpointing an immune pathway that fuels tumor growth only in females.

24 Jun 2026

New Progenitor Cell Platform Offers Scalable Source for Immunotherapy

In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages.

22 Jun 2026

Phage Surface Proteins Act as Molecular Anchors to Attach Cells

Bacteriophages, or phages, are viruses that infect bacteria and are not considered human pathogens. Yet researchers at the Translational Microbiology Laboratory of the Institute of Biochemistry, HUN-REN Biological Research Centre, Szeged, have shown that some gut phages can also physically interact with human cells.

13 Jun 2026

Collagen Exists as Liquid-Like Droplets Inside Cells

According to a recent study from the Centre for Genomic Regulation (CRG) in Barcelona, collagen, the protein that forms skin, bones, tendons, and organs, occurs inside cells as a liquid-like droplet rather than the long, rigid rod portrayed in textbooks during the past fifty years.

12 Jun 2026

Cryo-EM Study Unlocks Structural Secrets of RNA Therapeutics

RNA therapeutics have emerged as one of the most promising new classes of medicines. Eight small interfering RNA (siRNA) drugs have already been approved worldwide for the treatment of genetic diseases, yet scientists have not fully understood one of the most fundamental steps underlying their function: how Argonaute, the core protein responsible for gene silencing, becomes activated.

11 Jun 2026

Laverock Therapeutics Reports Key Oncology Research Milestones

Laverock Therapeutics, a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage oncology program for solid tumor indications.

From Laverock Therapeutics 11 Jun 2026

Microtubule Skeleton Determines How Heart Muscle Cells Change Under Stress

Microtubules, part of heart muscle cells' internal "skeleton," help determine how the heart changes shape under stress, and a common signaling pathway called the ERK pathway acts as a key controller of where the building materials for these cells' growth are delivered inside them, a pair of new studies show.

9 Jun 2026

Scientists Identify EHMT2 Enzyme as Main Cause of 5-FU Failure

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.

9 Jun 2026

Antibody-Directed Xenophagy Pathway Blocks Intracellular Infections From Spreading

Scientists have revealed the process by which cells can internally digest bacteria and viruses.

5 Jun 2026

Scientists Identify Microglia Immune State Changes for Novel Alzheimer’s Therapies

Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer's disease pathology leads to dementia.

5 Jun 2026

Study Shows How AI and Single Cell Science are Changing Modern Medicine

Recent technological advances have pushed the boundaries of cellular biology far beyond what was conceivable even decades ago

4 Jun 2026

MRM Health Rewarded a € 2.6 M VLAIO Research Grant to Accelerate the Development of Novel Therapeutics that Redefine the Treatment of Immune-Mediated Inflammatory Diseases

MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that it has been awarded a research grant of € 2.6M from Flanders Innovation and Entrepreneurship (VLAIO), a government organization with the goal to stimulate economic development in Flanders, Belgium.

29 May 2026

Researchers Find Simple Genetic Links for Extreme Traits

Researchers at the Icahn School of Medicine at Mount Sinai have found evidence that people who fall at the extreme high or low ends of certain traits, such as cholesterol, blood glucose, height, and age at menopause, are more likely to have a simple genetic explanation than previously thought.

28 May 2026

Molecular Blueprint Shows How Vital Gene Regulation Complexes Form

While scientists have known for over two decades that all cells use a strategy called RNA interference to regulate gene expression, a new study is the first to describe how a specific protein manages the step-by-step process of assembling the molecular complex that performs the regulatory job.

27 May 2026

Advanced Framework Improves Gene Set Enrichment Analysis to Uncover Hidden Multi-Omics Data Insights

Scientists at the Icahn School of Medicine at Mount Sinai have created a new artificial intelligence (AI) model that helps reveal how genes function together inside human cells, offering a powerful new way to understand biology and disease.

25 May 2026